Key points Globally, females are disproportionately affected by iron deficiency, owing to biological and socioeconomic factors as well as health system factors that deprioritize prevention and ...

The Times reports that AstraZeneca, the U.K.'s most valuable public company, is looking to move its listing from London to ...

AstraZeneca CEO discusses leaving London for US and Japan facing new, bigger tariff - Stock markets updates and business news ...

Meanwhile, the NSE Nifty closed 88 points lower (down 0.3%). Bajaj Finserv, L&T, HDFC Bank on the hand, were among the top ...

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca ...

From VR jellyfish to whale bones in class, Seadream Education is making waves with immersive, hands-on environmental learning ...

With AstraZeneca reported to be looking into moving its listing across the Atlantic, should investors buy the stock ahead of ...

AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...

Rising one place to number one overall, the British drugmaker has overtaken the NHS as the preferred destination for science ...

The Global Bioinformatics Market is expected to grow at a rate of 13-14% by 2029. The rising government initiatives and ...

The government must urgently abolish stamp duty on shares and abolish new cash ISAs to prevent the London Stock Exchange ...

AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country: Our Bureau, Bengaluru Wednesday, July 2, 2025, 15:15 Hrs [IST] AstraZeneca Pharma Indi ...